Pages that link to "Q35674263"
Jump to navigation
Jump to search
The following pages link to Changes in the activity of connective tissue matrix enzymes in the metabolic syndrome (Q35674263):
Displaying 8 items.
- Effect of elastin-derived peptides on the production of tissue inhibitor of metalloproteinase-1, -2, and -3 and the ratios in various endothelial cell lines (Q35758096) (← links)
- Impact of peroxisome proliferator-activated receptor γ on angiotensin II type 1 receptor-mediated insulin sensitivity, vascular inflammation and atherogenesis in hypercholesterolemic mice (Q35992156) (← links)
- Proof of Concept: Matrix metalloproteinase inhibitor decreases inflammation and improves muscle insulin sensitivity in people with type 2 diabetes (Q36427429) (← links)
- Comprehensive insight into immune regulatory mechanisms and vascular wall determinants of atherogenesis - emerging perspectives of immunomodulation (Q36686150) (← links)
- Significance of impaired serum gelatinases activities in metabolic syndrome. (Q37707926) (← links)
- Thrombin inhibition by dabigatran attenuates atherosclerosis in ApoE deficient mice (Q38271983) (← links)
- Ginkgo suppresses atherosclerosis through downregulating the expression of connexin 43 in rabbits (Q40549729) (← links)
- Vitamin D supplementation has no effect on matrix metalloproteinases-2, -9, and tissue inhibitor matrix metalloproteinase-1 in subjects with metabolic syndrome: A pilot study (Q92094264) (← links)